Assignee
KHAMAR BAKULESH MAFATLAL
IN·9 granted patents·4 pending applications·11 citations·filing 2002–2012
Top patents by PatentIndex Score
13 records- 0175US9029567B2Hypoglycemic compoundsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted May 12, 2015·2 cites·8 claims
- 0273US8647643B2Farnesoid-X-receptor antagonist as a vaccine adjuvantKHAMAR BAKULESH MAFATLAL·Filed 2009·Granted Feb 11, 2014·1 cites·5 claims
- 0372US8277778B2Vaccine adjuvantsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 2, 2012·2 cites·15 claims
- 0470US9795659B2Pharmaceutical composition of killed cells with substantially retained immunogenicityKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 24, 2017·2 cites·4 claims
- 0566US9345683B2Pharmaceutical composition of taxoidsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted May 24, 2016·2 cites·9 claims
- 0658US9789187B2Stable pharmaceutical composition for atherosclerosisKHAMAR BAKULESH MAFATLAL·Filed 2010·Granted Oct 17, 2017·1 cites·11 claims
- 0758US9474727B2Pharmaceutical compositions of curcuminKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 25, 2016·1 cites·12 claims
- 0858US8563517B2Dipeptidyl peptidase IV (DP-IV) compoundsKHAMAR BAKULESH MAFATLAL·Filed 2009·Granted Oct 22, 2013·0 cites·4 claims
- 0955US2013330375A1Therapeutic Cancer VaccineKHAMAR BAKULESH MAFATLAL·Filed 2012·Application pending·0 cites
- 1053US8110204B2Method of treating human-immunodeficiency virus (HIV) disease infectionKHAMAR BAKULESH MAFATLAL·Filed 2002·Granted Feb 7, 2012·0 cites·29 claims
- 1147US2009137633A1Stable pharmaceutical composition of rabeprazoleKHAMAR BAKULESH MAFATLAL·Filed 2004·Application pending·0 cites
- 1246US2013295648A1Pharmaceutical composition for treating cancerKHAMAR BAKULESH MAFATLAL·Filed 2012·Application pending·0 cites
- 1335US2013137852A1Novel compounds as dpp-iv inhibitors and process for preparation thereofKHAMAR BAKULESH MAFATLAL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KHAMAR BAKULESH MAFATLAL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →